Seeing Is Believing
Currently out of the existing stock ratings of Brandon Folkes, 103 are a BUY (86.55%), 1 are a SELL (0.84%), 15 are a HOLD (12.61%).
Analyst Brandon Folkes, currently employed at CIBC, carries an average stock price target met ratio of 33.69% that have a potential upside of 21.1% achieved within 221 days.
Brandon Folkes’s has documented 235 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANIP, ANI Pharmaceuticals at 09-Jul-2025.
Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for OMER (OMEROS) at 11/14/2024. The price target of $9 was fulfilled within 8 days with a profit of $2.05 (29.5%) receiving and performance score of 36.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6
$0.41 (7.33%)
$8
3 years 4 months 21 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Hold
$5
$-0.59 (-10.55%)
3 years 5 months 2 days ago
(13-Feb-2022)
0/1 (0%)
$-0.56 (-10.07%)
Hold
$4.5
$-1.09 (-19.50%)
3 years 5 months 25 days ago
(20-Jan-2022)
4/4 (100%)
$1.14 (33.93%)
167
Buy
$6.25
$0.66 (11.81%)
$5
4 years 2 months 10 days ago
(05-May-2021)
1/2 (50%)
$3.07 (96.54%)
287
Buy
$8
$2.41 (43.11%)
5 years 8 months 2 days ago
(13-Nov-2019)
1/2 (50%)
$2.26 (36.00%)
1683
Which stock is Brandon Folkes is most bullish on?
Which stock is Brandon Folkes is most reserved on?
What Year was the first public recommendation made by Brandon Folkes?